Additionally, note that the lower DDX3X levels were displayed in uveal melanoma, diffuse large B-cell lymphoma, thymoma, liver hepatocellular carcinoma, kidney papillary cell carcinoma, and skin cutaneous melanoma, which indicates that DDX3X might has a dual role in cancer progression. Here, DDX3X is linked to cancer.